Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
August 01, 2008
JTCB. 2008 Aug 1; 6 (2) : 059-063

Protein/Creatinine Ratio in Spot Urine: Proteinuria Indicator in Patients with Kidney Diseases

1 Atatürk Eğitim ve Araştırma Hastanesi, 1. Biyokimya Laboratuvarı, İzmir
2 Atatürk Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İzmir

Abstract

The reference method for the determination of urinary protein excretion in patients with kidney diseases is the measurement of 24-h protein excretion. But 24-h. urine collection is unreliable and cumbersome. So protein/creatinine ratio (P/C) in spot urine is used to determine proteinuria. In this study we investigated if P/C ratio in spot urine is reliable to determine proteinuria. This study included 60 subjects hospitalized in Izmir Ataturk Education Hospital Nephrology Clinic with different type of kidney diseases. P/C ratios in spot urines and protein excretion in 24 h. urine specimens were calculated. Measurement of 24 h. urine prot ein is considered as a reference method. We compared the two methods. There was a strong positive correlation between the results of the two methods (p<0.05, r=0.92) Area under the ROC curve was 0.946 when we evaluate P/C ratios. The best P/C cut-off values to detect abnormal or nephrotic proteinuria were, respectively, 0.15, 0.35 and 0.56.Our findings supported the use of spot urine P/C ratio to determine proteinuria in patients with kidney diseases.

Citation

Şentürk, Banu Arslan, Füsun Üstüner, Evren Akgöl, Demet Arslan İnce, and Mustafa Cirit. 2008. “Protein/Creatinine/Ratio/in/Spot/Urine:/Proteinuria/Indicator/in/Patients/With/Kidney/Diseases”. Journal of Turkish Clinical Biochemistry 6 (2):059-063. https://turkclinbiochem.org/index.php/pub/article/view/103.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.